News
President Biden kicks off health agenda with COVID actions, WHO outreach
January 21, 2021
President Biden issued an executive order requiring masks and physical distancing in all federal buildings.
News
Biden’s COVID-19 challenge: 100 million vaccinations in the first 100 days. It won’t be easy.
January 20, 2021
“I think it’s an attainable goal. I think it’s going to be extremely challenging,” said Claire Hannan, executive director of the Association of Immunization Managers.
News
HHS will drop buprenorphine waiver rule for most physicians
January 19, 2021
There were more than 83,000 deaths attributed to drug overdoses in the United States in the 12 months ending in June 2020.
News
Eliminating hepatitis by 2030: HHS releases new strategic plan
January 14, 2021
The United States “is currently facing unprecedented hepatitis A outbreaks, while progress in preventing hepatitis B has stalled, and hepatitis C rates nearly tripled.”
News
Feds to states: Give COVID-19 vaccine to 65+ and those with comorbidities
January 13, 2021
The federal government will also increase the number of sites eligible to receive vaccine – including some 13,000 federally qualified community health centers.
Article
VA Ramps up Vaccinations as COVID-19 Cases Continue to Rise
January 8, 2021
Facilities nationwide seeing surges in new cases and hospitalizations as rates in veterans and VA employees mirror national trends.
News
Anaphylaxis cases after COVID-19 vaccine rising but still rare: CDC
January 7, 2021
Health care providers should be ready to treat rare cases of anaphylaxis following administration of COVID-19 vaccines.
News
FDA warns about risk for false negatives from Curative COVID test
January 6, 2021
A negative result from the Curative PCR test “does not rule out COVID-19 and should not be used as the sole basis for treatment or patient management decisions.
News
CDC issues COVID-19 vaccine guidance for underlying conditions
December 29, 2020
The CDC guidance had specific information for people with HIV, weakened immune systems, and autoimmune conditions such as Guillain-Barré syndrome and Bell’s palsy.
News
Moderna’s COVID-19 vaccine deemed ‘highly effective,’ but further studies needed
December 23, 2020
The primary safety endpoint was to characterize the safety of the vaccine following one or two doses.